By Calvin Freiburger
The Justice Department attorney did not mention the Trump FDA’s recent admission linking the COVID shots to at least 10 child deaths so far.
The Trump Department of Justice (DOJ) is attempting to dismiss a whistleblower case against Pfizer over its COVID-19 shots, even as the Trump Food & Drug Administration (FDA) is beginning to admit their culpability in children’ s deaths.
As previously covered by LifeSiteNews, in 2021 the BMJ published a report on insider information from a former regional director of the medical research company Ventavia, which Pfizer hired in 2020 to conduct research for the company’s mRNA-based COVID-19 shot.
The regional director, Brook Jackson, sent BMJ “dozens of internal company documents, photos, audio recordings, and emails,” which “revealed a host of poor clinical trial research practices occurring at Ventavia that could impact data integrity and patient safety […] We also discovered that, despite receiving a direct complaint about these problems over a year ago, the FDA did not inspect Ventavia’s trial sites.”
According to the report, Ventavia “falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial.” Overwhelmed by numerous problems with the trial data, Jackson filed an official complaint with the FDA.
Jackson was fired the same day, and Ventavia later claimed that Jackson did not work on the Pfizer COVID-19 shot trial; but Jackson produced documents proving she had been invited to the Pfizer trial team and given access codes to software relating to the trial. Jackson filed a lawsuit against Pfizer for violating the federal False Claims Act and other regulations in January 2021, which was sealed until February 2022. That case has been ongoing ever since.
Last August, U.S. District Judge Michael Truncale dismissed most of Jackson’s claims with prejudice, meaning they could not be refiled. Jackson challenged the decision, but the Trump DOJ has argued in court to uphold it, Just the News reports, with DOJ attorney Nicole Smith arguing that the case concerns preserving the government’s unfettered power to dismiss whistleblower cases.
The rationale echoes a recurring trend in DOJ strategy that Politico described in May as “preserving executive power and preventing courts from second-guessing agency decisions,” even in cases that involve “backing policies favored by Democrats.”
Jackson’s attorney Warner Mendenhall responded that the administration “really sort of made our case for us” in effectively admitting that DOJ is taking the Fair Claims Act’s “good cause” standard for state intervention to mean “mere desire to dismiss,” which infringes on his client’s “First Amendment right to access the courts, to vindicate what she learned.”
Mendenhall added that in a refiled case, Jackson “may be able to bring a very different case along the same lines, but with the additional information” to prove fraud, whereas rejection would send the message that “if fraud involves government complicity, don’t bother reporting it.”
That additional information would presumably include the FDA’s recent admission that at least 10 children the agency has reviewed so far “died after and because of receiving COVID-19 vaccination.”
“The truth is we do not know if we saved lives on balance,” admitted FDA Chief Medical Officer Vinay Prasad in a recent leaked email. “It is horrifying to consider that the U.S. vaccine regulation, including our actions, may have harmed more children than we saved. This requires humility and introspection.”
The COVID shots have been highly controversial ever since the first Trump administration’s Operation Warp Speed initiative prepared and released them in a fraction of the time any previous vaccine had ever been developed and tested. As LifeSiteNews has extensively covered, a large body of evidence has steadily accumulated over the past five years indicating that the COVID jabs failed to prevent transmission and, more importantly, carried severe risks of their own.
Ever since, many have intently watched and hotly debated what President Donald Trump would do about the situation upon his return to office. Though he never backed mandates like former President Joe Biden did, for years Trump refused to disavow the shots to the chagrin of his base, seeing Operation Warp Speed as one of his crowning achievements. At the same time, during his latest run he embraced the “Make America Healthy Again” movement and its suspicion of the medical establishment more broadly.
So far, Trump’s second administration has rolled back several recommendations for the shots but not yet pulled them from the market, despite hiring several vocal critics of the COVID establishment and putting the Department of Health & Human Services under the leadership of America’s most prominent anti-vaccine advocate, Robert F. Kennedy Jr. Most recently, the administration has settled on leaving the current jabs optional but not supporting work to develop successors.
In a July interview, FDA Commissioner Marty Makary asked for patience from those unsatisfied by the administration’s handling of the shots, insisting more time was needed for comprehensive trials to get more definitive data.
Related
